We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




New Method to Reveal Bacterial Reaction to Antibiotics in Five Minutes Could Help Create Rapid Molecular Test

By LabMedica International staff writers
Posted on 24 May 2023
Print article
Image: New method reveals bacterial reaction to antibiotics within minutes (Photo courtesy of Freepik)
Image: New method reveals bacterial reaction to antibiotics within minutes (Photo courtesy of Freepik)

Severely sick patients suffering from bacterial infections often require immediate treatment to prevent serious health complications, making it vital for physicians to quickly identify the appropriate antibiotic. However, existing approaches to determining antibiotic resistance can involve extensive periods, sometimes hours or even days. This has led to the frequent prescription of broad-spectrum antibiotics, heightening the risk of antibiotic resistance. Now, a simple method has been developed that can detect bacterial response to antibiotics within just five minutes.

Researchers at Karolinska Institutet (Solna, Sweden) set out to reduce the unwarranted use of antibiotics by devising a rapid method to assess how bacteria react to different environmental conditions, including antibiotic administration. They developed the 5PSeq method, which relies on sequencing the messenger RNA (mRNA) that is broken down by the bacteria as they synthesize proteins. The researchers employed the 5PSeq method to examine mRNA breakdown intermediates in isolated species and complex microbiomes. They tested the method on 96 bacterial species from diverse phyla in complex clinical samples, such as fecal, gut, and vaginal samples, as well as compost samples. In a matter of minutes, the researchers were able to determine whether the bacteria were reacting to the antibiotic treatment; the effect was most noticeable after about half an hour.

By utilizing metadegradome sequencing - parallel analysis of RNA ends - the team characterized 5′P mRNA decay intermediates in all 96 species, including Bacillus subtilis, Escherichia coli, Synechocystis spp., and Prevotella copri. They discovered co-translational mRNA degradation to be common among bacteria and generated a degradome atlas for the 96 species, facilitating the further study of RNA degradation mechanisms in bacteria. In addition to measuring antibiotic resistance, the method can be employed to help scientists understand how bacteria manage diverse environmental pressures, and how they interact both with each other and with their hosts. The researchers plan to continue investigating complex intestinal samples to gain deeper insights into the interactions of bacterial communities in the gut and their effects on human health. The aim is to refine the method and develop a rapid molecular test for clinical application.

“We demonstrate that metadegradome sequencing provides fast, species-specific posttranscriptional characterization of responses to drug or environmental perturbations,” the researchers wrote. “Our work paves the way for the application of metadegradome sequencing to investigation of posttranscriptional regulation in unculturable species and complex microbial communities.”

Related Links:
Karolinska Institutet 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.